z-logo
open-access-imgOpen Access
Amiodarone-Induced Bone Marrow Granulomas: An Unusual Cause of Reversible Pancytopenia
Author(s) -
Andrew J. Erie,
Rebecca F. McClure,
Alexandra P. Wolanskyj
Publication year - 2010
Publication title -
hematology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.239
H-Index - 12
ISSN - 2038-8330
DOI - 10.4081/hr.2010.e6
Subject(s) - pancytopenia , medicine , amiodarone , bone marrow , sarcoidosis , granuloma , bone marrow diseases , bone marrow suppression , pathology , surgery , chemotherapy , atrial fibrillation
Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient’s pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom